Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinquan Liang

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
The Science of the Total Environment|November 15, 2020
Application of diatomite for gallic acid removal from molasses wastewaterXiaorong Song, Chenglin Li, Zhihui Chai, et al.
International Journal of Biological Macromolecules|September 29, 2020
Arginine-modified magnetic chitosan: Preparation, characterization and adsorption of gallic acid in sugar solutionZhihui Chai, Chenglin Li, Yuan Zhu, et al.
Acta Biochimica Et Biophysica Sinica|February 28, 2024
Targeted disruption of the <i>BCR-ABL</i> fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cellsJianling Zeng, Xinquan Liang, Lili Duan, et al.
Translational Lung Cancer Research|April 15, 2026
Integrated management of immunotherapy and radiotherapy for patients with metastatic non-small cell lung cancer: a narrative review of current landscape and future directionsXinquan Liang, Fengxue Li, Yingying Zhang, et al.
Journal of Hematology & Oncology|July 6, 2017
Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemiaQian Fan, Hui Liu, Xinquan Liang, et al.
Cancer Medicine|January 27, 2026
Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor TherapyFengxue Li, Lili Qiao, Xinquan Liang, et al.
Cancer Medicine|February 9, 2024
Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapyGuangyang Weng, Jingya Huang, Na An, et al.
Annals of Hematology|September 18, 2023
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort studyGuangyang Weng, Jingya Huang, Xin He, et al.
Journal of Internal Medicine|October 26, 2022
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemiaGuangyang Weng, Yu Zhang, Guopan Yu, et al.
Cancer|March 7, 2018
Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantationLi Xuan, Yu Wang, Fen Huang, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
The Science of the Total Environment|November 15, 2020
Application of diatomite for gallic acid removal from molasses wastewaterXiaorong Song, Chenglin Li, Zhihui Chai, et al.
International Journal of Biological Macromolecules|September 29, 2020
Arginine-modified magnetic chitosan: Preparation, characterization and adsorption of gallic acid in sugar solutionZhihui Chai, Chenglin Li, Yuan Zhu, et al.
Acta Biochimica Et Biophysica Sinica|February 28, 2024
Targeted disruption of the <i>BCR-ABL</i> fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cellsJianling Zeng, Xinquan Liang, Lili Duan, et al.
Translational Lung Cancer Research|April 15, 2026
Integrated management of immunotherapy and radiotherapy for patients with metastatic non-small cell lung cancer: a narrative review of current landscape and future directionsXinquan Liang, Fengxue Li, Yingying Zhang, et al.
Journal of Hematology & Oncology|July 6, 2017
Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemiaQian Fan, Hui Liu, Xinquan Liang, et al.
Cancer Medicine|January 27, 2026
Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor TherapyFengxue Li, Lili Qiao, Xinquan Liang, et al.
Cancer Medicine|February 9, 2024
Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapyGuangyang Weng, Jingya Huang, Na An, et al.
Annals of Hematology|September 18, 2023
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort studyGuangyang Weng, Jingya Huang, Xin He, et al.
Journal of Internal Medicine|October 26, 2022
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemiaGuangyang Weng, Yu Zhang, Guopan Yu, et al.
Cancer|March 7, 2018
Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantationLi Xuan, Yu Wang, Fen Huang, et al.
Pageof 6